Latest News

The innovative approach uses lab-grown heart tissue made from reprogrammed adult stem cells, delivered through a tiny incision rather than opening the entire chest cavity.

Both organizations plan to develop a long-term framework that facilitates knowledge exchange, clinical cooperation, and the joint development of physician training programs.

The World Health Organization has listed Nipah among its top ten priority diseases alongside pathogens like Covid-19 and Zika due to its potential to trigger epidemics.

Kenmare Bio will obtain worldwide development and commercialization rights to an experimental oral small molecule known as FHND5032, with the exception of Greater China, where Chia Tai Feng Hai will retain control.

Eli Lilly will obtain exclusive global rights to advance these programmed recombinases through preclinical studies, clinical development, and eventual commercialization.

The investment will enhance AstraZeneca’s existing manufacturing sites in Wuxi, Beijing, Qingdao, and Taizhou, which already serve patients in China and across 70 international markets.

The new facility promises to revolutionize medical care for residents of Pleebo City and the surrounding communities, who have long endured the burden of traveling significant distances to access surgical services.

The AI-powered system automatically analyzes computed tomography (CT) scans that were originally performed for unrelated medical reasons, identifying osteoporotic pathological signs without requiring additional examinations.

The standalone Eye Care Center occupies 750 square meters of space, delivering an impressive 83% increase in clinical capacity compared to the previous facility.

The company will showcase its technology on the ABHI UK Pavilion alongside a robust delegation of UK life sciences and health technology companies.